カテゴリ： 世界, 医療/バイオ, Market Monitor Global

全身性アスペルギルス症＆全身性カンジダ症のグローバル市場展望 2023年-2029年：ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他

■ 英語タイトル：Systemic Aspergillosis and Systemic Candidasis Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8694）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8694
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[全身性アスペルギルス症＆全身性カンジダ症のグローバル市場展望 2023年-2029年：ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の全身性アスペルギルス症＆全身性カンジダ症市場規模と予測を収録しています。・世界の全身性アスペルギルス症＆全身性カンジダ症市場：売上、2018年-2023年、2024年-2029年
・世界の全身性アスペルギルス症＆全身性カンジダ症市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の全身性アスペルギルス症＆全身性カンジダ症市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ボリコナゾール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

全身性アスペルギルス症＆全身性カンジダ症のグローバル主要企業は、Novartis AG、 Pfizer, Inc、 Sanofi-Aventis、 Merck & Co., Inc、 Enzon Pharmaceuticals, Inc、 Bayer AG、 Astellas Pharma, Inc、 GlaxoSmithKline plc、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、全身性アスペルギルス症＆全身性カンジダ症のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の全身性アスペルギルス症＆全身性カンジダ症市場：タイプ別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症＆全身性カンジダ症市場：タイプ別市場シェア、2022年
・ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他

世界の全身性アスペルギルス症＆全身性カンジダ症市場：用途別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症＆全身性カンジダ症市場：用途別市場シェア、2022年
・CPA、ABPA、消化管カンジダ症、泌尿生殖器カンジダ症、その他

世界の全身性アスペルギルス症＆全身性カンジダ症市場：地域・国別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症＆全身性カンジダ症市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における全身性アスペルギルス症＆全身性カンジダ症のグローバル売上、2018年-2023年
・主要企業における全身性アスペルギルス症＆全身性カンジダ症のグローバル売上シェア、2022年
・主要企業における全身性アスペルギルス症＆全身性カンジダ症のグローバル販売量、2018年-2023年
・主要企業における全身性アスペルギルス症＆全身性カンジダ症のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis AG、 Pfizer, Inc、 Sanofi-Aventis、 Merck & Co., Inc、 Enzon Pharmaceuticals, Inc、 Bayer AG、 Astellas Pharma, Inc、 GlaxoSmithKline plc、 Abbott

*************************************************************

・調査・分析レポートの概要
全身性アスペルギルス症＆全身性カンジダ症市場の定義
市場セグメント
世界の全身性アスペルギルス症＆全身性カンジダ症市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の全身性アスペルギルス症＆全身性カンジダ症市場規模
世界の全身性アスペルギルス症＆全身性カンジダ症市場規模：2022年 VS 2029年
世界の全身性アスペルギルス症＆全身性カンジダ症市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの全身性アスペルギルス症＆全身性カンジダ症の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の全身性アスペルギルス症＆全身性カンジダ症製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他
全身性アスペルギルス症＆全身性カンジダ症のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：CPA、ABPA、消化管カンジダ症、泌尿生殖器カンジダ症、その他
全身性アスペルギルス症＆全身性カンジダ症の用途別グローバル売上・予測

・地域別市場分析
地域別全身性アスペルギルス症＆全身性カンジダ症市場規模 2022年と2029年
地域別全身性アスペルギルス症＆全身性カンジダ症売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis AG、 Pfizer, Inc、 Sanofi-Aventis、 Merck & Co., Inc、 Enzon Pharmaceuticals, Inc、 Bayer AG、 Astellas Pharma, Inc、 GlaxoSmithKline plc、 Abbott
...

This report aims to provide a comprehensive presentation of the global market for Systemic Aspergillosis and Systemic Candidasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Aspergillosis and Systemic Candidasis. This report contains market size and forecasts of Systemic Aspergillosis and Systemic Candidasis in global, including the following market information:
Global Systemic Aspergillosis and Systemic Candidasis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Systemic Aspergillosis and Systemic Candidasis Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Systemic Aspergillosis and Systemic Candidasis companies in 2022 (%)
The global Systemic Aspergillosis and Systemic Candidasis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Voriconazole Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Systemic Aspergillosis and Systemic Candidasis include Novartis AG, Pfizer, Inc, Sanofi-Aventis, Merck & Co., Inc, Enzon Pharmaceuticals, Inc, Bayer AG, Astellas Pharma, Inc, GlaxoSmithKline plc and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Aspergillosis and Systemic Candidasis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Systemic Aspergillosis and Systemic Candidasis Market Segment Percentages, by Type, 2022 (%)
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Other
Global Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Systemic Aspergillosis and Systemic Candidasis Market Segment Percentages, by Application, 2022 (%)
CPA
ABPA
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other
Global Systemic Aspergillosis and Systemic Candidasis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Systemic Aspergillosis and Systemic Candidasis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Aspergillosis and Systemic Candidasis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Systemic Aspergillosis and Systemic Candidasis revenues share in global market, 2022 (%)
Key companies Systemic Aspergillosis and Systemic Candidasis sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Systemic Aspergillosis and Systemic Candidasis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Systemic Aspergillosis and Systemic Candidasis, market overview.
Chapter 2: Global Systemic Aspergillosis and Systemic Candidasis market size in revenue and volume.
Chapter 3: Detailed analysis of Systemic Aspergillosis and Systemic Candidasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Systemic Aspergillosis and Systemic Candidasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Systemic Aspergillosis and Systemic Candidasis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Systemic Aspergillosis and Systemic Candidasis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Aspergillosis and Systemic Candidasis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Aspergillosis and Systemic Candidasis Overall Market Size
2.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size: 2022 VS 2029
2.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Systemic Aspergillosis and Systemic Candidasis Sales: 2018-2029
3 Company Landscape
3.1 Top Systemic Aspergillosis and Systemic Candidasis Players in Global Market
3.2 Top Global Systemic Aspergillosis and Systemic Candidasis Companies Ranked by Revenue
3.3 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Companies
3.4 Global Systemic Aspergillosis and Systemic Candidasis Sales by Companies
3.5 Global Systemic Aspergillosis and Systemic Candidasis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Systemic Aspergillosis and Systemic Candidasis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Systemic Aspergillosis and Systemic Candidasis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidasis Players in Global Market
3.8.1 List of Global Tier 1 Systemic Aspergillosis and Systemic Candidasis Companies
3.8.2 List of Global Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidasis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Systemic Aspergillosis and Systemic Candidasis Market Size Markets, 2022 & 2029
4.1.2 Voriconazole
4.1.3 Liposomal Amphotericin B
4.1.4 Systemic Oral Azoles
4.1.5 Topical Antifungal Agents
4.1.6 Other
4.2 By Type – Global Systemic Aspergillosis and Systemic Candidasis Revenue & Forecasts
4.2.1 By Type – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2023
4.2.2 By Type – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2024-2029
4.2.3 By Type – Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share, 2018-2029
4.3 By Type – Global Systemic Aspergillosis and Systemic Candidasis Sales & Forecasts
4.3.1 By Type – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2023
4.3.2 By Type – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2024-2029
4.3.3 By Type – Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share, 2018-2029
4.4 By Type – Global Systemic Aspergillosis and Systemic Candidasis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Systemic Aspergillosis and Systemic Candidasis Market Size, 2022 & 2029
5.1.2 CPA
5.1.3 ABPA
5.1.4 Gastrointestinal Candidiasis
5.1.5 Genitourinary Tract Candidiasis
5.1.6 Other
5.2 By Application – Global Systemic Aspergillosis and Systemic Candidasis Revenue & Forecasts
5.2.1 By Application – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2023
5.2.2 By Application – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2024-2029
5.2.3 By Application – Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share, 2018-2029
5.3 By Application – Global Systemic Aspergillosis and Systemic Candidasis Sales & Forecasts
5.3.1 By Application – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2023
5.3.2 By Application – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2024-2029
5.3.3 By Application – Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share, 2018-2029
5.4 By Application – Global Systemic Aspergillosis and Systemic Candidasis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Systemic Aspergillosis and Systemic Candidasis Market Size, 2022 & 2029
6.2 By Region – Global Systemic Aspergillosis and Systemic Candidasis Revenue & Forecasts
6.2.1 By Region – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2023
6.2.2 By Region – Global Systemic Aspergillosis and Systemic Candidasis Revenue, 2024-2029
6.2.3 By Region – Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share, 2018-2029
6.3 By Region – Global Systemic Aspergillosis and Systemic Candidasis Sales & Forecasts
6.3.1 By Region – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2023
6.3.2 By Region – Global Systemic Aspergillosis and Systemic Candidasis Sales, 2024-2029
6.3.3 By Region – Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2029
6.4.2 By Country – North America Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2029
6.4.3 US Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.4.4 Canada Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.4.5 Mexico Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2029
6.5.2 By Country – Europe Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2029
6.5.3 Germany Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.4 France Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.5 U.K. Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.6 Italy Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.7 Russia Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.8 Nordic Countries Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.5.9 Benelux Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2029
6.6.2 By Region – Asia Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2029
6.6.3 China Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.6.4 Japan Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.6.5 South Korea Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.6.6 Southeast Asia Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.6.7 India Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2029
6.7.2 By Country – South America Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2029
6.7.3 Brazil Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.7.4 Argentina Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales, 2018-2029
6.8.3 Turkey Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.8.4 Israel Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.8.5 Saudi Arabia Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
6.8.6 UAE Systemic Aspergillosis and Systemic Candidasis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Summary
7.2.2 Pfizer, Inc Business Overview
7.2.3 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.2.4 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer, Inc Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.3.4 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Merck & Co., Inc
7.4.1 Merck & Co., Inc Company Summary
7.4.2 Merck & Co., Inc Business Overview
7.4.3 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.4.4 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co., Inc Key News & Latest Developments
7.5 Enzon Pharmaceuticals, Inc
7.5.1 Enzon Pharmaceuticals, Inc Company Summary
7.5.2 Enzon Pharmaceuticals, Inc Business Overview
7.5.3 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.5.4 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.5.5 Enzon Pharmaceuticals, Inc Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.6.4 Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Astellas Pharma, Inc
7.7.1 Astellas Pharma, Inc Company Summary
7.7.2 Astellas Pharma, Inc Business Overview
7.7.3 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.7.4 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma, Inc Key News & Latest Developments
7.8 GlaxoSmithKline plc
7.8.1 GlaxoSmithKline plc Company Summary
7.8.2 GlaxoSmithKline plc Business Overview
7.8.3 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.8.4 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline plc Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Systemic Aspergillosis and Systemic Candidasis Major Product Offerings
7.9.4 Abbott Systemic Aspergillosis and Systemic Candidasis Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity, Analysis
8.1 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity, 2018-2029
8.2 Systemic Aspergillosis and Systemic Candidasis Production Capacity of Key Manufacturers in Global Market
8.3 Global Systemic Aspergillosis and Systemic Candidasis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Systemic Aspergillosis and Systemic Candidasis Supply Chain Analysis
10.1 Systemic Aspergillosis and Systemic Candidasis Industry Value Chain
10.2 Systemic Aspergillosis and Systemic Candidasis Upstream Market
10.3 Systemic Aspergillosis and Systemic Candidasis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Systemic Aspergillosis and Systemic Candidasis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の全身性アスペルギルス症及び全身性カンジダ症市場2022年：市場規模予測（～2028年）
  • 浸透性殺菌剤のグローバル市場展望 2023年-2029年：チオファネートメチル、ポリミキシン、テブコナゾール、その他
  • 放射線治療装置のグローバル市場展望 2023年-2029年：体外照射放射線治療装置、体内照射放射線治療装置、全身照射放射線治療装置
  • がん放射線療法のグローバル市場展望 2023年-2029年：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法
  • ダビガトランのグローバル市場展望 2023年-2029年：プラダクサ、プラダクス、プラザキサ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8694 )"全身性アスペルギルス症＆全身性カンジダ症のグローバル市場展望 2023年-2029年：ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他" (英文：Systemic Aspergillosis and Systemic Candidasis Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。